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Abstract
BACKGROUND: Gestational trophoblastic diseases (GTDs) are a group of rare human tumors by abnormal 
trophoblastic proliferation. GTD is neoplasia that develops from the trophoblastic element of blastocyst. In this case, 
some specific features of the trophoblast are retained, while the hCG (Human Chorionic Gonadotropin) synthesis 
and invasion potential of the underlying tissues are preserved. 
CASE REPORT: We reported a 55-year-old patient with invasive (destructive) mole hydatidiform “FIGO I” with invasion 
in myometrium wall. This diagnostic was suggested by abnormal (dysfunctional) vaginal bleeding, amenorrhea period, 
and low abdominal pain. Our paraclinical investigation was physical examination, transabdominal, and transvaginal 
ultrasound and complete blood count. Transabdominal and transvaginal ultrasound reveal enlarged uterus volume, 
with dimensions 18/12/5 cm and with Doppler rich blood supply through myometrium and endometrium. Therapeutic 
method applied was abdominal hysterectomy and bilateral salpingo-oophorectomy. Anatomopathological report 
revealed a complete invasive mole. After the surgical intervention, the patient was no treated with methotrexate as 
prophylactic chemotherapy (recommended by oncologists) because the level of β-hCG was very low.
CONCLUSION:  Examining the tissue after a miscarriage in women at extreme ages should raise a suspicion of 
mole. Molar pregnancy should be excluded in these cases.
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Introduction
Invasive mole is the penetration of molar 
tissue (complete or partial mole) into myometrium or 
uterine vasculature. Edematous villus and proliferative 
trophoblasts invade myometrium, so they can be 
distinguished from choriocarcinoma.
Human chorionic gonadotropin (HCG) level 
(>100000 mIU/ml), excessive uterine enlargement, 
and theca lutein cyst size ≥6 cm are considered as 
high risks for developing post-molar tumors (high-risk 
mole). The most common symptom of invasive mole is 
persistent vaginal bleeding after evacuation of molar 
pregnancy (sub-involution of uterus and persistent 
theca lutein cyst is another symptom). The rise in βHCG 
titer is a laboratory test for diagnosis of an invasive 
mole in follow-up of molar pregnancy. Although definite 
diagnosis of invasive mole is based on pathology, 
with βHCG or radiologic diagnosis, invasive mole is 
diagnosed as well [1], [2], [3], [4], [5].
GTD describes a number of gynecologic 
tumors, which classification is as follows:
I. Premalignant form is representing:
1. Hydatidiform mole which is complete or partial.
II. Malignant: 
1. Invasive mole
2. Choriocarcinoma
3. Placental site trophoblastic tumor
4. Epithelioid trophoblastic tumor.
Invasive mole may arise from any pregnancy 
event, although in most cases, it is diagnosed after 
molar pregnancy. The invasive mole (chorioadenoma 
destruens) is a form of complete hydatidiform 
molar pregnancy evolution. Although this disease is 
characterized by an aggressive development that it 
is actually locally invasive, usually without distance 
dissemination, sometimes can also occur distant 
metastases. It is defined as a category of mole that 
penetrates and may even perforate the uterine wall. 
Rarely, it can spread to other organs, such as vagina, 
vulva, and lung. The invasive mole can be distinguished 
from choriocarcinoma by the presence of villi [7], [8]. 
The invasive mole classic describe macroscopic is 
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characterized with trophoblastic invasion of myometrium 
with villous structures and microscopic is characterized 
by citotrofoblast hyperplasia, syncytial elements, and 
villous structures persistence. The invasive mole can 
be distinguished from choriocarcinoma by the presence 
of chorion villi [7], [10].
In rare cases, metastasis occurred and the 
most common sites were lungs (80%), vagina (30%), 
pelvis (20%), liver (10%), brain (10%), and bowel and 
kidney and spleen (<5%) which were other metastatic 
sites. However, metastasis to ovary from invasive 
mole is rare. About 5% to 6% of ovarian tumors come 
from metastasis of other organs. Metastasis can occur 
from direct extension of another pelvic neoplasm or by 
hematogenous or lymphatic spread or by transcoelomic 
dissemination. The possibility of metastasis to ovary is 
extremely rare which is even much lower than that of 
non-gestational primary ovary choriocarcinoma with an 
incidence of 1 in 3.7×108.
Ovarian non-gestational choriocarcinoma is a 
major differential diagnosis. Metastasis to the omentum 
is very rare in invasive mole. Invasive mole is curable 
with chemotherapy, but hysterectomy decreases 
the need for multiple courses of chemotherapy, and 
in patients with heavy bleeding or sepsis for control 
of complication and stabilization, chemotherapy is 
needed [1], [4], [6], [8], [10].
Here, we present a case with invasive mole 
with abnormal uterine bleeding (or dysfunctional uterine 
bleeding), low abdomen pain, and very increased 
thickness of the endometrium. Management and 
treatment with abdominal hysterectomy with bilateral 
salpingo-oophorectomy, in this case, was successful.
Case Report
A 55-year-old woman was admitted to MHAT 
NiaMed Ltd’s Department of obstetrics and gynecology 
complaining of non-stop bleeding from the genital area 
for over one calendar month. Patient’s history indicated 
by herself showed that she had been taking birth control 
pills until the age of 45 due to irregular menstrual cycle. 
First day of last regular menstrual cycle was in October 
2019. The next month (November 2019) the cycle did not 
present. In December 2019, the cycle resumed for duration 
of 6 days, whereas on day 3, the patient experienced two 
heavy hemorrhagic episodes. On day 7, the hemorrhaging 
stopped, but on day 9, it resumed, although not as heavy 
as previously experienced and continued until the day of 
admission to MHAT NiaMed Ltd, namely, January 27, 2020.
On examination post-admission January 27, 
2020, the patient presents as a woman in good overall 
clinical health. On further gynecological examination, the 
uterus was discovered to be enlarged corresponding to 
15–16 gestation weeks, with a soft texture and irregular 
form. The transvaginal sonography determined the 
following finding: Uterus with size 15–12–8 cm, with 
myoma located intramurally at the front uterine wall. The 
thickness of the endometrium was 44 mm, presenting 
with non-homogenous grape-like characteristics and 
saturated blood supply. The right ovary – observed 
formation approximately 2.5 cm in size. The left ovary – 
observed normal (Figure 1).
In terms of differential diagnosis, several 
diagnoses were discussed, such as benign and malignant 
pathology of the endometrium and ovaries. An X-ray 
examination of the lungs was performed, which did not 
show abnormal variations. Blood tests were conducted, 
showing results within the norm. On January 27, 2020, 
the patient was hospitalized. On the basis of the patient 
history as described above and the data gathered during 
the patient’s examination, a decision was made to 
perform laparohysterectomy totalis cum adnexibus.
Figure 1: Transvaginal sonography 
Blood analysis as hemoleucograma, 
coagulograma, liver enzymes, glucose, urea, and 
creatinine was within normal limits (Table 1). The chest 
X-ray was also a normal finding (Figure 2).
Figure 2: The chest X-ray
The abdominal wall was breached in the 
Pfannenstiel method. In situ findings: Uterus with size 
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was found. Right ovary – corpus luteum 2.5 cm was in 
size.
The result obtained by the pathologists 
provided us with the following information:
Macroscopic
Enlarged uterus (more than 15 cm) was found. 
A tumor formation, from the thicket of cavum uteri, 
with a soft consistency, built from a set of grape-like 
spheres, some of which filled with clear liquid and some 
of which filled with rusty-brown liquid, ranging in size 
from several mm to 1 cm. Hemorrhages and necrotic 
areas, infiltration in the myometrium were discovered. 
The right ovary with a corpus luteum in size of 2.5 cm 
was found. (Figure 4).
Figure 4: Sections of tumor formation
Histologically
1. Uterus: Tumor formation, built from highly 
dilated, edematous chorial villi with no blood 
vessels in them was found. Decidua and 
trophoblastic elements with moderate cellular 
and nuclear atypism, with extensive tumor 
necrosis and hemorrhage and penetration, 
covering about 1/3 of the myometrium. The 
presence of single multi-core monstrous cell 
elements [Figures 5].
The find responds to invasive (destructive) 
mole hydatidosis FIGO I.
corresponding to 15–16 gestation weeks, right ovary – 
corpus luteum 2.5 cm in diameter (Figure 3). 
Figure 3: Macroscopic picture of the resected uterus
On slicing the uterus open, a tumor foundation 
was found with a spongy consistency and many grape-
like spheres, some of which filled with clear liquid and 
some of which filled with rusty-brown liquid, ranging 
from 0.5 mm to 1 cm in size; heavy hemorrhaging 
and necrotic areas infiltrate that the myometrium was 
observed. After discussing the macroscopic view with 
a pathologist, a destructive mola was considered as 
a diagnosis; therefore, a blood sample for β-hCG was 
taken, with a result 26879 mIU/L. The return of the 
histological samples from the operation showed the 
following results:
Macroscopic: Uterus enlarged by more than 15 
cm in diameter. A tumor formation filling cavum uteri with 
spongy consistency formed by numerous grape-like 
spheres, some of which filled with clear liquid and some 
of which filled with rusty-brown liquid, ranging in size 
from several mm to 1 cm. Abundance of hemorrhagic 
and necrotic sections with infiltration in the myometrium 
Table 1: Hemoleucogram, coagulogram, liver enzymes, 
glucose, urea, and creatinine
Patient value Normal range
Blood
Hb 112  g/L 120-160
Ht 31.2  %   37.0-48.0
Er 3.41 x 10^12/L   4.20-5.60
Leu 8.1 x 10^9/L 3.5-10.5
Lymph 1.3  x 10^9/L   08.-4.0
Mid 0.6  x 10^9/L    01.-0.9
Gran 6.2  x 10^9/L      2.0-7.0
Lymph 16.3 %     20.0-40.0
Mid 7.0 %   3.0-9.0
Gran 76.7 % 50.0-70.0
MCV 91.6 fl   82.0-95.0
MCH 32.8 pg        27.0-33.0
MCHC 358  g/l   320-360
RDWCV 13.6 %   11.5-14.5
RDWSD 46.8 fl     35.0-56.0
PLT 240 x 10^9/L      140-440
MPV 10.0 fl     7.0-11.0
PDW 15.6        15.0-17.0
PCT 0.240 % 0.108-0282
Prothrombin time 11.8s Prothrombin time
Prothrombin activity 119.1% Prothrombin activity
INR 0.85  INR
Fibrinogen  Quantity 3.74 g/l Fibrinogen  Quantity
Fibrinogen Time 9.4 s Fibrinogen Time
Urine
Protein (-)negative Negative  
Glucose (-)negative Negative 
Ketone (-)negative Negative
Urobilinogen N Negative
Bilirubin (-)negative Negative
Sediment analyses 7-8 RBC and BC on the field Negative
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2. Cervix: Normal histological findings without 
abnormalities
3. Ovaries: Right ovary-corpus luteum, left 
ovary-normal histological findings without 
abnormalities
4. Fallopian tubes: Normal histological findings 
without abnormalities.
FIGO stage Description
I Gestational trophoblastic tumors strictly confined to the uterine corpus
II Gestational trophoblastic tumors extending to the adnexa or to the vagina 
but limited to the genital structures
III Gestational trophoblastic tumors extending to the lungs, with or without 
genital tract involvement
IV All other metastatic sites
There were no pre-, intra-, and post-operative 
complications.
The blood result of beta HCG after 10 days 
was 878.79 mIU/ ml (Table 2).
Table 2: Beta HCG in blood
Hormone 30.01.2020 y 10.02.2020 y 02.03.2020 y. 07.04.2020 y
β-human chorionic 
gonadotropin
26879 mIU/L 878.79 mIU/L 111.34 mIU/L 47.41 mIU/L
The patient was sent to an oncological 
committee for discussion whether subsequent 
chemotherapy is needed. The decision of the 
oncological committee was a follow-up with a re-review 
of histological slides, control on beta-HCG in 3 weeks 
(Table 2) and control computed tomography (CT) 
scan.
The re-review of histological slides shows: 
Cervix – normal histological findings without 
abnormalities; uterus – invasive (destructive) mole 
hydatidosis; and ovaries and fallopian tubes – normal 
histological findings without abnormalities.
Control CT scan shows normal anatomical 
findings after hysterectomy, without CT data for 
active the underlying disease. According to RECIST 
criteria – complete response was achieved [5], [7], 
[8], [9].
The patient’s condition in the late post-operative 
period was good without any data on subsequent 
general and gynecological complications.
Discussion
Gestational trophoblastic disease (GTD) 
is class of tumors characterized by an abnormal 
proliferation of trophoblast. It is known that the 
appearance of pregnancy in perimenopause period is 
extremely low, rare, and unique. There are a number 
of factors that make both conception and a healthy 
pregnancy harder for older women. First in this 
woman in perimenopause, the ovulation becomes 
irregular, making conception more difficult. In other 
sites, men are constantly producing new sperm, but 
women are born with all eggs reserve. By the time 
four decades have passed, those eggs have aged and 
increasing the chance of chromosomal abnormalities. 
Teenagers and perimenopause women are most 
affected by GTD. All women of reproductive age may 
potentially develop a GTD. This is the reason why 
histopathological analysis is necessary to exclude 
trophoblastic disease in all cases that are clinically 
indicated or not. Even more, suspicion should be 
high and should exclude the disease of a product of 
conception derived from miscarriages, in patients at 
extreme age. It was assumed that our patient is in 
perimenopause period (no hormonal investigations 
were carried for this diagnosis) with dysfunctional 
(abnormal) uterine bleeding [3]. The first diagnosis 
considered was dysfunctional (abnormal) uterine 
bleeding (due to the height of the endometrium and 
the inability to desquamate and evacuate on its own, 
due to the hormonal deficiency that occurred during 
this period of the woman’s development) and fibroid 
uterus. Any other causes of endometrial bleeding 
also were considered: Endometrial or ovarian 
malignancies or benign injury. A trophoblastic disease 
was not estimated in this case, and due to that β-hCG 
measurement was not performed initially. Most women 
will only need a minor surgery for a trophoblastic 
disease (biopsy curettage), to remove the molar 
tissue. However, a small percentage of this will need 
chemotherapy. In case of our patient, it was decided 
that a hysterectomy should be performed. No residual 
trophoblastic disease was found after the surgical 
treatment, and references of the β-hCG levels remain 
undetectable.
Conclusion
The number of pregnancy in perimenopause 
period is very low. The incidence of molar pregnancy 
increases at the extremes of reproductive age, 
teenagers, and perimenopause women. With this 
Figure 5: The presence of single multi-core monstrous cell elements 
a b
c d
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case that we have chosen, we want to emphasize that 
this condition can occur in relatively advanced age, 
especially during perimenopause period. Examining 
the tissue after a miscarriage in women at extreme 
ages should raise a suspicion of mole. Molar pregnancy 
should be excluded in these cases.
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